Mangoceuticals (MGRX) Net Cash Flow Growth (1y) (2024 - 2026)
Mangoceuticals (MGRX) Net Cash Flow Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | -43.71% |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -2,023.91% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | -564.99% |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -39.60% |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 294.02% |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 28,500.00% |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | -128.00% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 175.22% |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | -1,170.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,170.46% |
| Mar 31, 2026 | -12,932.40% |
| Dec 31, 2025 | 14,311.36% |
| Sep 30, 2025 | 191.46% |
| Jun 30, 2025 | -94.08% |
| Mar 31, 2025 | 101.41% |
| Dec 31, 2024 | 98.58% |
| Sep 30, 2024 | 75.69% |
| Jun 30, 2024 | 144.51% |
| Mar 31, 2024 | -122.70% |